CoChat

Fluoxetine, a Selective Serotonin Uptake Inhibitor, for the Treatment of Outpatients with Major Depression

BYERLEY, WILLIAM F., REIMHERR, FRED W., WOOD, DAVID R., GROSSER, BERNARD I. · 1988 · Journal of Clinical Psychopharmacology

The DOI matches its Crossref record.

Abstract

In a double-blind, placebo-controlled study the authors found that fluoxetine, a potent and selective inhibitor of serotonin reuptake, was an effective antidepressant in moderately depressed, ambulatory outpatients. Typical adverse effects reported by patients treated with fluoxetine included agitation, nausea, fatigue, and insomnia. Compared to imipramine, fluoxetine was associated with fewer complaints of dry mouth, constipation, and dizziness.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004714-198804000-00005

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 85

Metadata

Authors
BYERLEY, W. F., REIMHERR, F. W., WOOD, D. R., & GROSSER, B. I.
Affiliations
University of Utah (US)
Venue
Journal of Clinical Psychopharmacology
Published
1988-04
Volume
8
Issue
2
Pages
112???115
ISSN
0271-0749 (ISSN-L)
OpenAlex
W1975957737
Cited by
80
References
0
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2020: 2 · 2018: 6 · 2017: 3 · 2016: 1 · 2015: 4 · 2013: 3 · 2012: 1
FWCI
3.74
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
Keywords
fluoxetine, selective serotonin reuptake inhibitors, major depressive disorder, outpatients, antidepressant efficacy, adverse effects, imipramine, xerostomia, constipation, dizziness, agitation, insomnia
MeSH terms
Adult, Ambulatory Care, Clinical Trials as Topic, Depressive Disorder, Double-Blind Method, Female, Fluoxetine, Humans, Imipramine, Male, Middle Aged, Propylamines, Random Allocation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fluoxetine, a Selective Serotonin Uptake Inhibitor, for the Treatment of Outpatients with Major Depression. https://app.cochat.ai/papers/10.1097/00004714-198804000-00005
The paper
BYERLEY, W. F., REIMHERR, F. W., WOOD, D. R., & GROSSER, B. I. (1988). Fluoxetine, a Selective Serotonin Uptake Inhibitor, for the Treatment of Outpatients with Major Depression. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-198804000-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.